Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction.
about
Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell modelUrinary biomarkers as a diagnostic tool for acute kidney injury.Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.Biomarkers of nephrotoxic acute kidney injuryUrinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsUrinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptionsBiomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.Renal function in diabetic nephropathy.Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubulesProtective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.Human FABP1 T94A variant enhances cholesterol uptakeAn evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome.Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy.Heart-fatty acid-binding protein as a marker for early detection of acute myocardial infarction and stroke.Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients.Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysisUrinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.Emerging urinary biomarkers in the diagnosis of acute kidney injuryFunctional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell CarcinomaUrinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.Tubular and glomerular injury in diabetes and the impact of ACE inhibition.The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application.Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury?Biomarkers in diabetic nephropathy: Present and future.Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules.Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein.Predicting acute kidney injury: current status and future challenges.Components of Boiogito Suppress the Progression of Hypercholesterolemia and Fatty Liver Induced by High-Cholesterol Diet in Rats.Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury.Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.Heart-type fatty acid-binding protein and its relation with morphological changes in rat myocardial damage model induced by isoproterenol.Biomarkers of acute kidney injury.Serum liver-type fatty acid-binding protein predicts recovery of graft function after kidney transplantation from donors after cardiac death.Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers.
P2860
Q28363321-8FA9A5F2-7E9A-4B2D-84E2-A9C51969E0C7Q30450879-8EF6C298-EB06-4980-AE96-C15A967CC649Q33613330-531F5032-9057-4D5D-B9E8-70FFE91BBA0DQ33687717-A8A339E0-DF6D-4CB4-AED8-86A7CBAED2B5Q33873146-364ACB0D-9EAC-405D-89E1-C59B23A57FA5Q34704298-6157B889-B05A-464A-9E3C-7390D4D7508BQ34760887-8AC138A0-5BF0-465E-B065-10DA36310C41Q34814081-B878F5AF-C4D7-44E9-9205-FCE3CC295C45Q34828809-E1648F25-628D-427F-9E94-9DF5A6BDC0BAQ34877735-1FC8E128-78DE-4938-90AE-7A76AEC10726Q35103241-114E5EBE-A07F-4C79-A59B-25391888E804Q35468668-84208614-5FCA-4B48-A47F-69DFBB40635EQ35502801-B283DF36-04B4-495E-9DFF-25CB1FFE3EFAQ35533422-F2E67E80-B2DF-4E8F-BD50-ED1AB794B9CCQ35771734-7A171879-2E94-46BE-B6FE-1337728700C5Q36106116-91DC6409-0C96-466E-A893-678D902651ECQ36202893-98001D63-7F3F-4071-A66D-91B3750D2899Q36614485-2C3C4139-9E89-4C34-B17D-007CECCCEB01Q36625568-5BC28BA9-EDFE-4FC7-AA31-B48B4DC5ACD5Q36942114-D175D4AC-548C-41B4-9E2E-FB076B40FABEQ37010079-C3397DFA-69B8-4559-AB74-2154A7CBD9FBQ37028663-0B362996-5620-4912-9AE1-09D79B738FB1Q37197335-2948B996-BF60-41D0-A0F5-0097F4DA8B94Q37319249-2CD58D16-FC59-4768-851A-70B370715E66Q37594791-FE0F055C-1025-45ED-B5A7-EE6CA8778970Q37771880-E050FA65-54EB-4CB8-ABDF-DF205CC20082Q37866846-B017232A-FE7E-4531-801C-66F23A732BA8Q38003686-4EA0248B-C6A0-458A-892D-3FFF199AA702Q38290083-8C2507B0-CE46-47AC-BC6D-804CEDCD5E14Q38330892-7E8F62A5-20EB-4974-81FE-37C47BB1ADE9Q38354002-EF356F6E-26FD-4D48-9230-C394D11B9D8AQ38669818-6FE005FC-90DD-493D-9858-0B9C91220CACQ39759671-A0F3771C-0D20-44E9-A9F5-A283A3818650Q40827374-E7463312-7621-43FD-92BD-F279AD04F7CDQ41816605-50F04726-B0E1-4203-A9CC-0465AEB80BC7Q41956187-E535BD30-DD99-4613-9D6D-F6F5000E2A87Q42553072-24C8613F-C89C-47E5-A9E4-E48B4C4420AFQ44567997-DE79A90F-3A23-46FC-92BA-6A52EDF9F96EQ46317296-9145BE60-02F7-4923-8622-6A3C4AE59A73Q46727130-46D2EF05-8DA6-477B-BB2A-7B830C5F9DBE
P2860
Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Molecular identification of th ...... ase polymerase chain reaction.
@en
Molecular identification of th ...... ase polymerase chain reaction.
@nl
type
label
Molecular identification of th ...... ase polymerase chain reaction.
@en
Molecular identification of th ...... ase polymerase chain reaction.
@nl
prefLabel
Molecular identification of th ...... ase polymerase chain reaction.
@en
Molecular identification of th ...... ase polymerase chain reaction.
@nl
P2093
P2860
P356
P1433
P1476
Molecular identification of th ...... ase polymerase chain reaction.
@en
P2093
E M van de Westerlo
J H Veerkamp
R G Maatman
T H van Kuppevelt
P2860
P304
P356
10.1042/BJ2880285
P407
P478
288 ( Pt 1)
P577
1992-11-01T00:00:00Z